細菌性涎腺炎市場：按類型、按細菌類型、按腺體類型、按藥物類別、按分銷管道、按地區

Bacterial Sialadenitis Market, By Type, By Type of Bacteria, By Gland Type, By Drug Class, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

細菌性唾液腺炎市場規模預計在 2025 年達到 5.434 億美元，預計到 2032 年將達到 7.697 億美元，2025 年至 2032 年的年複合成長率為 5.1%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	5.434億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	5.10%	2032年價值預測	7.697億美元

涎腺炎是指主要唾液腺（包括腮腺（位於雙耳前方）、下頷下腺（位於口腔底部舌下）和舌下（位於口腔後部的舌下））的腫脹和增大。它可能是急性（突發性）、慢性（長期性）或復發性的。此病是由唾液腺導管感染或阻塞引起的。細菌性涎腺炎的常見病原體是金黃色葡萄球菌，但其他病原體也可能是病原體。細菌性涎腺炎通常伴隨疼痛，並可能伴隨發燒和寒顫。受累的唾液腺腫脹、發紅、觸痛，並且通常中央變色，這可能提示存在膿腫。

預防措施包括保持良好的口腔衛生、多喝水以及治療可能增加細菌性唾液腺炎風險的潛在疾病。定期進行口腔護理並避免危險因子有助於降低患病風險。細菌性唾液腺炎的主要治療方法是抗生素治療，該療法針對的是導致感染的特定細菌。此外，也建議補充水分、熱敷和唾液腺按摩，以促進唾液分泌並緩解症狀。在某些情況下，可能需要手術切除唾液腺結石或排放膿瘍。

市場動態：

由於唾液腺感染疾病、唾液腺炎和修格蘭氏症候群症等自體免疫疾病的盛行率不斷上升，預計未來幾年全球細菌性唾液腺炎市場將顯著成長。

預計高昂的治療費用和與感染相關的併發症將阻礙全球細菌性唾液腺炎市場的成長。

本研究的主要特點

本報告對全球細菌性唾液腺炎市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，介紹了主要企業的情況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球細菌性涎腺炎市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球細菌性涎腺炎市場的各種策略矩陣來更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 543.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.10%	2032 Value Projection:	USD 769.7 Mn

Sialadenitis is swelling and enlargement of the major salivary glands, the parotid (in front of each ear), submandibular (under the tongue on the floor of the mouth) or sublingual (below the tongue in the back of the mouth). It can be acute (sudden) or chronic (long-term) or recurrent. The condition can be caused by infection or by a blockage of the gland's ducts. A common cause of bacterial sialadenitis is Staphylococcus aureus, but other organisms may also be responsible. Bacterial sialadenitis is usually painful and may be accompanied by fever and chills. The affected gland is swollen, red and tender and usually has a central area of discoloration, which may indicate an abscess.

Preventive measures include maintaining good oral hygiene, drinking enough water, and addressing underlying conditions that increase the risk of bacterial sialadenitis. Regular dental care and avoiding risk factors can help reduce the likelihood of developing the condition. The primary treatment for bacterial sialadenitis is antibiotic therapy to target the specific bacteria causing the infection. Adequate hydration, warm compresses, and gland massage may also be recommended to promote saliva flow and relieve symptoms. In some cases, surgical intervention may be necessary to remove salivary stones or drain abscesses.

Market Dynamics:

The global bacterial sialadenitis market is expected to witness significant growth in the coming years owing to rising incidence of conditions such as salivary gland infections, sialadenitis, and autoimmune diseases such as Sjogren's syndrome.

High cost of treatment and complications associated with the infection are expected to hinder growth of the global bacterial sialadenitis market over the forecast.

Key features of the study:

This report provides an in-depth analysis of the global bacterial sialadenitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bacterial sialadenitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Allergan plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bacterial sialadenitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial sialadenitis market

Detailed Segmentation:

By Type:
- Acute
- Chronic
Type of Bacteria:
- Staphylococcus aureus
- Streptococcus viridans
- Pseudomonas aeruginosa
- Escherichia coli
- Others (Haemophilus influenza, etc.)
By Gland Type:
- Parotid
- Submandibular
- Sublingual
By Drug Class
- Antibiotics
- Dicloxacillin
- Cephalosporin
- Clindamycin
- Analgesics
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Ecommerce
By Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Company Profiles:
- Pfizer Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Novartis AG
- Sanofi S.A.
- Johnson & Johnson
- Abbott Laboratories
- Eli Lilly and Company
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Roche Holding AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Allergan plc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bacterial Sialadenitis Market, By Type
- Market Bacterial Sialadenitis Market, By Type of Bacteria
- Market Bacterial Sialadenitis Market, By Gland Type
- Market Bacterial Sialadenitis Market, By Drug Class
- Market Bacterial Sialadenitis Market, By Distribution Channel
- Market Bacterial Sialadenitis Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Bacterial Sialadenitis Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Bacterial Sialadenitis Market, By Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Chronic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Bacterial Sialadenitis Market, By Type of Bacteria, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Streptococcus viridans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Bacterial Sialadenitis Market, By Gland Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Paratoid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Submandibular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Bacterial Sialadenitis Market, By Drug Class, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Dicloxacillin
  - Cephalosporin
  - Clindamycin
Analgesic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

9. Bacterial Sialadenitis Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Ecommerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

10. Bacterial Sialadenitis Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - North Africa
  - South Africa
  - Central Africa

11. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views